Fintel reports that on May 16, 2025, Jones Trading downgraded their outlook for Oncolytics Biotech (NasdaqCM:ONCY) from Buy ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

Headshot of Dieter Weinand Dieter Weinand, Chairman of the Board of Sibylla Biotech Milan, Italy, May 8, 2025 – Sibylla Biotech today announced the appointment of Dieter Weinand as Chairman of its ...

Vir Biotechnology, Inc.’s VIR share price has dipped by 5.45%, which has investors questioning if this is right time to buy.

Privately-held Italian firm Sibylla Biotech today announced the appointment of Dieter Weinand as chairman of its board of ...

The office in Penzberg is CRB's 21st office overall, and its third in Europe -- joining Stuttgart, Germany, and Basel, ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

The entrepreneur’s London penthouse is filled with bitcoin-inspired artworks, trippy sculptures and dinosaur skulls. Its an ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Many biotech executives are careful to give their ... the University itself faded into the background. Harvard’s Return But, ever so slowly, Harvard is trying to change course.

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...